Defeng Ye, Chengcheng Zhang, Wencheng Shao, Lin Lin, Xi Chen, Liang Wu
{"title":"FPPS Downregulation Attenuates Endoplasmic Reticulum Stress in Pulmonary Epithelial Cells","authors":"Defeng Ye, Chengcheng Zhang, Wencheng Shao, Lin Lin, Xi Chen, Liang Wu","doi":"10.1002/jgm.70024","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>The airway epithelium is the primary target of the trachea in lung transplant rejection and epithelial cell injury are frequently observed in lung transplants. Farnesyl pyrophosphate synthase (FPPS), a pivotal enzyme in the mevalonate pathway, synthesizes isoprenoid compounds like FPP and GGPP. This study found upregulated expression of FPPS in the epithelial cells of the tracheal transplant rat model and the use of the FPPS inhibitor zoledronic acid reduced the tracheal epithelial cell damage. Using CRISPR/CAS9, FPPS was knocked down in pulmonary-derived epithelial cells, and RNA sequencing analysis revealed alterations in the gene expression profile, notably involving significant reductions in multiple endoplasmic reticulum stress-related genes, including the ATF4/TRIB3 pathway and the ERN1/XBP1 pathway, which were further confirmed at the protein level. Additionally, treatment with zoledronic acid exhibited inhibitory effects on endoplasmic reticulum stress in the tracheal transplant rat model. Furthermore, FPPS knockdown and Inhibition were found to suppress the expression of multiple amino acid transporters, including SLC7A5, resulting in decreased intracellular levels of multiple amino acids, reduced mTORC1 pathway activity, and enhanced autophagic function. In summary, this study identified the protective roles of FPPS inhibition in epithelial cells of the tracheal transplant model, potentially mediated through reductions in endoplasmic reticulum stress, decreased mTORC1 activity, and augmented downstream autophagic processes.</p>\n </div>","PeriodicalId":56122,"journal":{"name":"Journal of Gene Medicine","volume":"27 6","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Gene Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jgm.70024","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The airway epithelium is the primary target of the trachea in lung transplant rejection and epithelial cell injury are frequently observed in lung transplants. Farnesyl pyrophosphate synthase (FPPS), a pivotal enzyme in the mevalonate pathway, synthesizes isoprenoid compounds like FPP and GGPP. This study found upregulated expression of FPPS in the epithelial cells of the tracheal transplant rat model and the use of the FPPS inhibitor zoledronic acid reduced the tracheal epithelial cell damage. Using CRISPR/CAS9, FPPS was knocked down in pulmonary-derived epithelial cells, and RNA sequencing analysis revealed alterations in the gene expression profile, notably involving significant reductions in multiple endoplasmic reticulum stress-related genes, including the ATF4/TRIB3 pathway and the ERN1/XBP1 pathway, which were further confirmed at the protein level. Additionally, treatment with zoledronic acid exhibited inhibitory effects on endoplasmic reticulum stress in the tracheal transplant rat model. Furthermore, FPPS knockdown and Inhibition were found to suppress the expression of multiple amino acid transporters, including SLC7A5, resulting in decreased intracellular levels of multiple amino acids, reduced mTORC1 pathway activity, and enhanced autophagic function. In summary, this study identified the protective roles of FPPS inhibition in epithelial cells of the tracheal transplant model, potentially mediated through reductions in endoplasmic reticulum stress, decreased mTORC1 activity, and augmented downstream autophagic processes.
期刊介绍:
The aims and scope of The Journal of Gene Medicine include cutting-edge science of gene transfer and its applications in gene and cell therapy, genome editing with precision nucleases, epigenetic modifications of host genome by small molecules, siRNA, microRNA and other noncoding RNAs as therapeutic gene-modulating agents or targets, biomarkers for precision medicine, and gene-based prognostic/diagnostic studies.
Key areas of interest are the design of novel synthetic and viral vectors, novel therapeutic nucleic acids such as mRNA, modified microRNAs and siRNAs, antagomirs, aptamers, antisense and exon-skipping agents, refined genome editing tools using nucleic acid /protein combinations, physically or biologically targeted delivery and gene modulation, ex vivo or in vivo pharmacological studies including animal models, and human clinical trials.
Papers presenting research into the mechanisms underlying transfer and action of gene medicines, the application of the new technologies for stem cell modification or nucleic acid based vaccines, the identification of new genetic or epigenetic variations as biomarkers to direct precision medicine, and the preclinical/clinical development of gene/expression signatures indicative of diagnosis or predictive of prognosis are also encouraged.